Invention Grant
- Patent Title: BSL2vcvc-lg polypeptides
- Patent Title (中): BSL2vcvc-IG多肽
-
Application No.: US13711855Application Date: 2012-12-12
-
Publication No.: US08674076B2Publication Date: 2014-03-18
- Inventor: Glen Eugene Mikesell , Han Chang , Robert James Peach
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Stephen C. D'Amico
- Main IPC: C07K14/00
- IPC: C07K14/00 ; C07K16/46

Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.
Public/Granted literature
- US20130144042A1 B7-RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION Public/Granted day:2013-06-06
Information query